EIM
AGIO icon

Essex Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Essex Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.49M Buy
+103,177
New +$2.93M 0.55% 59
2018
Q4 		– Sell
-13,235
Closed -$1.02M – 477
2018
Q3 		$1.02M Buy
13,235
+2,233
+20% +$180K 0.12% 228
2018
Q2 		$927K Buy
+11,002
New +$959K 0.12% 231

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Essex Investment Management's AGIO Position: Q1 2026 in Review

Essex Investment Management opened a new position in Agios Pharmaceuticals (AGIO) in Q1 2026: 103,177 shares worth $3.49M. The stake represents 0.55% of the portfolio and ranks #59 among its holdings. This is a return to the name: Essex Investment Management previously reported a position in AGIO as recently as Q3 2018.

Essex Investment Management first reported a position in AGIO in Q2 2018 and has held it in 3 quarters since. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Essex Investment Management held 103,177 shares of Agios Pharmaceuticals worth $3.49M as of Q1 2026.
  • Agios Pharmaceuticals was a new Essex Investment Management position in Q1 2026.
  • Agios Pharmaceuticals made up 0.55% of Essex Investment Management's portfolio in Q1 2026, its #59 holding.
  • Essex Investment Management first reported a position in Agios Pharmaceuticals in Q2 2018 and has held it in 3 quarters since.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Essex Investment Management's 13F filing for Q1 2026, filed 11 May 2026.